### 2.2.1	In vitro / physico-chemical Data

A literature search was performed to collect available information on physiochemical properties of alfentanil. The obtained information from literature is summarized in the table below. 

| **Parameter**   | **Unit** | **Value**       | Source                                                       | **Description**                                 |
| :-------------- | -------- | --------------- | ------------------------------------------------------------ | ----------------------------------------------- |
| MW              | g/mol    | 416.52          |                                                              | Molecular weight                                |
| pK<sub>a</sub>  |          | 6.5 (base)      | [Jansson 2008](# 5 References)                               | Acid dissociation constant                      |
| Solubility (pH) | mg/L     | 992.0 (6.5)     | [Baneyx 2014](# 5 References)                                | Solubility                                      |
| logP            |          | 2.1, 2.2        | [Baneyx 2014](# 5 References), [Jansson 2008](# 5 References) | Partition coefficient between octanol and water |
| fu              | %        | 8.6, 10.0, 12.0 | [Baneyx 2014](# 5 References), [Edginton 2008](#5 References), [Almond 2016](#5 References) | Fraction unbound in plasma                      |


### 2.2.2	Clinical Data

A literature search was performed to collect available clinical data on alfentanil in healthy adults.

#### 2.2.2.1	Model Building

The following studies were used for model building:

| Publication                      | Arm / Treatment / Information used for model building        |
| :------------------------------- | :----------------------------------------------------------- |
| [Ferrier 1985](#5 References)    | Healthy subjects with a single iv dose of 0.05 mg/kg         |
| [Kharasch 1997](#5 References)   | Healthy subjects with a single iv dose of 0.02 mg/kg         |
| [Kharasch 2004](#5 References)   | Healthy subjects with a single iv dose of 0.015 mg/kg, healthy subjects with a single oral dose of 0.06 mg/kg |
| [Kharasch 2011](#5 References)   | Healthy subjects with a single iv dose of 0.015 mg/kg, healthy subjects with a single oral dose of 0.075 mg/kg |
| [Kharasch 2011b](#5 References)  | Healthy subjects with an iv dose of 1 mg, healthy subjects with an oral dose of 1 mg |
| [Kharasch 2012](#5 References)   | Healthy subjects with a single iv dose of 0.02 mg/kg         |
| [Meistelman 1987](#5 References) | Healthy subjects with a single dose of 0.02 mg/kg            |
| [Phimmasone 2001](#5 References) | Healthy subjects with a single dose of 0.015 mg/kg           |
